Risk factors causing the development of infection and inflammation of the lower urinary tract

Cover Page

Cite item


Persistence as well as high survival rate and resistance of microorganisms belong to the key reasons promoting symptoms of lower urinary tract diseases. They can stay active for a long time and can substantially deteriorate the life quality of patients suffering from chronic infections and inflammations in the wall of the urinary bladder even after the eradication of the pathogen. Recent studies in the field of clinical microbiology reflect serious qualitative and quantitative changes in the infection incidence structure, which is mainly related to changes in the bacterial pathogenicity. Pathogenicity island genes control the synthesis of different adhesins, invasins, hemolysins and toxins (hemolysin, cytotoxic necrotizing factor type 1, etc.) as well as iron ion absorption system, which are essential for the pathogen propagation and activity in tissues. The determination of genetic determinants will provide a new insight into the bacterial evolution process and will help to understand the reason of prompt formation and propagation of virulent strains as well as fast development of the infection and inflammation in the lower urinary tract, which may explain different severity of the pathology and symptoms of the lower urinary tract.

About the authors

A. A. Kamalov

Lomonosov Moscow State University

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

L. A. Khodyreva

Lomonosov Moscow State University

Email: Khodyreva60@mail.ru
Russian Federation

A. A. Dudareva

Lomonosov Moscow State University

Email: noemail@neicon.ru
Russian Federation

A. N. Nizov

Lomonosov Moscow State University

Email: noemail@neicon.ru
Russian Federation


  1. Российские национальные рекомендации «Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов». М., 2013; (5)
  2. Hooton T.M. Reccurent urinary tract infection in women. Int J Antimicrob Agents 2001; 17 (4); 259-268.
  3. Lundstredt A.C., Leijonhufvud I., Ragnarsdottir B. et al. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 2007; 195 (8); 1227-1234.
  4. Hooton T.M. Reccurent urinary tract infection in women. Int J Antimicrob Agents 2001; 17 (4); 259-268.
  5. Nicolle L.A. Asimptomatic bacteriuria in the elderly. Infect Dis Clin North Am 1997; 11 (3): 647-662.
  6. Суфияров А.Д. Актуальные проблемы консервативной урологии. Менопаузальный цистит. Цисталгия. Под ред. Р.Х. Галеева. Казань; МЕДДОК 2007, 128
  7. Damiano R., Cicione A. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease. Ther Adv Urol 2011; 3 (5); 223-232
  8. Geppetti P., Nassini R., Materazzi S., Benemei S. The concept of neurogenic inflammation. BJU Int 2008; 101 (Suppl.3); 2-6
  9. Parsons C.L., Lilly J.D., Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 1991; 145 (4); 732-735.
  10. Siracusano S., Cucchi S., Ciciliato S. et al. Urinary levels of giycosaminoglycans in patients with idiopathic detrusor overactivity. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20 (12); 1477-1480.
  11. Nomiya M., Sagawa K., Yazaki J. et al. Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia. Neurourol Urodyn 2012; 31 (1); 185-189.
  12. Avelino A., Cruz C., Nagy I., Cruz E. Vanilloid receptor expression in the rat urinary tract. Neuroscience 2002; 109 (4); 787-798.
  13. Arya L.A., Northington G.M., Asfaw T. et al. Evidence of bladder oversensitivity in the absence of an infection in premenopausal women with a history of recurrent urinary tract infections. BJU Int 2012; 110 (2); 247-251.
  14. Супотницкий М.В. Микроорганизмы,токсины и эпидемии. Учебник 2010, глава 1.3-12
  15. Российские национальные рекомендации «Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов», 2013; 20-25
  16. Дорофеев С.П., Камалов А.А. Современные взгляды на проблему хронического простатита. РМЖ 2003; 11 (4): 736-742
  17. Адаскевич В.П. Инфекции, передаваемые половым путем. М., 1999; 327
  18. Micenková L., Štaudová B., Bosák J. et al. Bacteriocin-encoding genes and ExPEC virulence determinants are associated in human fecal Escherichia coli strains. BMC Microbiol 2014; 14: 109
  19. Брод П. Плазмиды, М,1982; 157
  20. Mecsas J.J., Strauss E.J. Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands. Emerg Infect Dis 1996; 2 (4); 270-288
  21. Бондаренко В.М., Фиалкина С.В., Лысенко Т.И. Генетические детерминанты патогенности штаммов Escherichia coli, изолированных из мочи и фекалий детей с различными клиническими вариантами инфекций мочевой системы. Детские инфекции 2004; (3): 21-23
  22. Вершинин А.Е., Бондаренко В.М., Ходырева Л.А., Перепанова Т.С. Значение обнаружения геномных маркеров островов патогенности у Escherichia coli в урологической практике. Клиническая лабораторная диагностика 2006; (10); 50-51
  23. Кашкин К.П., Бехало В.А. Стратегия иммунолабораторных исследований в клинике инфекционных болезней (лекция). Клиническая лабораторная диагностика 2004; (3): 23-25

Copyright (c) 2015 Kamalov A.A., Khodyreva L.A., Dudareva A.A., Nizov A.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies